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Recently, Shiang and colleagues have identified the gene
responsible for Startle disease (1). This disease also known as
hereditary hyperplexia or Kok disease is characterized by marked
but transient infantile hypertonia and exaggerated startle response
(2). Sequence analysis of the a\ subunit of the inhibitory glycine
receptor (GLRA1) showed a mutation at the same codon 271
in four out of seven tested families (Gl 192A and Gl 192T) (1).
We have analyzed this gene in a family of Swiss origin and found
the Gl 192A mutation changing an ARG to a LEU codon. This
report confirms that the GLRA1 gene is responsible for Startle
disease and describes a simple digestion-based assay for the
detection of codon 271 mutation.
The proband, a 17-year old girl of Swiss origin, was referred
to our Hospital for diagnosis and treatment of numerous episodes
of falling and myclonia in response to stimuli. She is the second
daughter of non-consanguineous parents. Her older sister and
mother both suffer abnormal startle reflex. The mutations
described by Shiang etal. (1) at codon 271 involve a TaqI (and
Xhol) site which allows for their rapid detection by restriction
enzyme digestion. In the normal sequence, the TaqI site TCGA
is present and complete digestion of PCR-amplified genomic
DNA will produce two fragments of equal size. If, however, a
mutation is introduced, the mutated site will not be cut and 2
bands will be seen, one from the normal and one from the mutated
chromosome. In order to test for these mutations, DNA was
extracted from peripheral lymphocytes and exon 6 of GLRA1
was amplified using the described primers without the GC-clamp
(1). Amplicons were digested with TaqI at 65°C in the
recommended buffer, fragments were separated on a 7%
poly aery lamide mini-gel for 60 min. at 60 W and the gel was
stained with ethidium bromide.
Figure 1 shows the TaqI digestion of the PCR products from
the reported family. Affected individuals reveal 2 bands while
only one is present in the unaffected father. Because destruction
of the TaqI site could be due to mutation in any of the 4 bases
defining the recognition site of the enzyme, amplicons from the
proband were subcloned in pUC 18 and one clone showing loss
of the TaqI site was sequenced on an A.L.F. automated sequencer
to determine the exact mutation. The mutation found was a G
to A transition at position 1192.
Thus, 50% of the families analyzed at a molecular level present
a Gl 192A mutation. This may arise from a common ancestor
or from the presence of a mutational hot spot at that particular
location. CpG dinucleotides are frequently involved in point
mutations probably as the result of methylation-deamination.
Deamination of a 5'-methylated CpG dinucleotide in the non-
sense strand would create a CpA at the sense strand and could
thus be responsible for 3 out of 4 mutations at codon 271.
However, the fact that another point mutation has occurred at
the same position would also suggest that Arginine at position
271 is critical for the function of the inhibitory glycine receptor
gene.
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Figure 1. Agarose gel of TaqI digested and control PCR-amplified DNA stained
with ethidium bromide. N: not cut; C: TaqI cut. M5 is a DNA molecular weight
marker (marker V from Boehringer Mannheim GmbH, lowest band on the gel
is 184 tip).
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